Jin David 4

What Happened

• Jin David, Chief Financial Officer of Fortress Biotech (FBIO), received an award of 400,000 restricted stock units (RSUs) on 2026-06-22. The award was granted at $0.00 (i.e., no cash purchase); vested RSUs will be settled in shares of common stock. This is a compensation award rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-22; Form 4 filed: 2026-06-24 (filed within the typical 2-business-day window).
• Award: 400,000 RSUs at $0.00 per unit. RSUs vest in four equal annual installments, with the first vesting on January 5, 2027, subject to continued service; vested units settle into shares. (Footnote F1)
• Holdings note: filing states total holdings include 1,230,000 shares underlying previously granted deferred RSUs. The 400,000 RSU award is additional and subject to the vesting schedule. (Footnote F2)
• Transaction type: Award/Grant (code A) — not an immediate purchase or sale; no immediate cash value realized.

Context

• RSU awards are a form of equity compensation for service and do not reflect an immediate market purchase or sale. Because these RSUs vest over time and convert to shares only upon vesting, they are a forward-looking compensation grant rather than an immediate bullish or bearish trading signal. Monitor vesting dates if you track potential future dilution or insider holdings.